{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:05:21Z","timestamp":1768352721065,"version":"3.49.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To provide a comprehensive summary of the published data on cause of death in patients with acute respiratory distress syndrome (ARDS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>PubMed (January 2015 to April 2024), bibliographies of relevant articles, and ARDS Network and Prevention &amp; Early Treatment of Acute Lung Injury (PETAL) network websites.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>Observational studies and clinical trials that reported on cause of death in greater than or equal to 30 patients with ARDS, not obtained from death certificates. Animal studies, case reports, review articles, study protocols, and studies in pediatrics were excluded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>Causes of death among ARDS patients who died were extracted and tabulated along with other pertinent study characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>We identified 15 observational studies (nine non-COVID ARDS, five COVID-related ARDS; one both) and five clinical trials (all non-COVID ARDS). Mutually exclusive prespecified categories were used for recording the cause of death in only eight studies although studies differed in the categories included and their definitions. When multiple organ failure was a predetermined category, it was the most common cause of death recorded (~50% of deaths), followed by respiratory causes with proportions varying from 16% to 42% depending on nomenclature (e.g., refractory hypoxemia, pulmonary causes) and definitions. However, the largest observational study in non-COVID ARDS (964 deaths), did not include multiple organ failure as a predetermined category, and found that pulmonary failure (42%) and cardiac failure (37%) were the most common causes of death. In COVID-related ARDS observational studies, pulmonary reasons were the most reported cause of death (up to 88%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Few studies have reported cause of death in patients with ARDS. In those that do, cause of death categories and definitions used are heterogeneous. Further research is needed to see whether a more rigorous and unified approach to assigning and reporting cause of death in ARDS would help identify more relevant endpoints for the assessment of targeted treatments in clinical trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001147","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T03:34:11Z","timestamp":1724384051000},"page":"e1147","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Understanding Causes of Death in Patients With Acute Respiratory Distress Syndrome: A Narrative Review"],"prefix":"10.1097","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-9823","authenticated-orcid":false,"given":"Susan E.","family":"Bromley","sequence":"first","affiliation":[{"name":"EpiMed Communications, Abingdon, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaweh","family":"Shakery","sequence":"additional","affiliation":[{"name":"Research & Development, Bayer AG, Berlin, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pareen","family":"Vora","sequence":"additional","affiliation":[{"name":"Integrated Evidence Generation, Bayer AG, Berlin, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artin","family":"Atabaki","sequence":"additional","affiliation":[{"name":"New Product Portfolio, Bayer AG, Berlin, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reimer","sequence":"additional","affiliation":[{"name":"Research & Development, Bayer AG, Berlin, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"McDermott","sequence":"additional","affiliation":[{"name":"Research & Development, Bayer AG, Berlin, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Hajizadeh","sequence":"additional","affiliation":[{"name":"Integrated Evidence Generation, Bayer AG, Berlin, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"R1-20240822","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(22)01439-8","article-title":"Acute respiratory distress syndrome in adults: Diagnosis, outcomes, long-term sequelae, and management.","volume":"400","author":"Gorman","year":"2022","journal-title":"Lancet"},{"key":"R2-20240822","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: Causes, pathophysiology, and phenotypes.","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"key":"R3-20240822","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"R4-20240822","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(21)00439-6","article-title":"Acute respiratory distress syndrome.","volume":"398","author":"Meyer","year":"2021","journal-title":"Lancet"},{"key":"R5-20240822","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/diagnostics10121053","article-title":"Diagnosis and management of acute respiratory distress syndrome in a time of COVID-19.","volume":"10","author":"Kassirian","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"R6-20240822","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury.","volume":"353","author":"Rubenfeld","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-20240822","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa032193","article-title":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.","volume":"351","author":"Brower","year":"2004","journal-title":"N Engl J Med"},{"key":"R8-20240822","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"key":"R9-20240822","year":"2006"},{"issue":"12 Suppl 2","key":"R10-20240822","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/PCC.0000000000003161","article-title":"Definition, incidence, and epidemiology of pediatric acute respiratory distress syndrome: From the second pediatric acute lung injury consensus conference.","volume":"24","author":"Yehya","year":"2023","journal-title":"Pediatr Crit Care Med"},{"key":"R11-20240822","article-title":"National Vital Statistics System: Possible Solutions to Common Problems in Death Certification.","year":"1997"},{"key":"R12-20240822","article-title":"Publications."},{"key":"R13-20240822","article-title":"Bibliography."},{"key":"R14-20240822","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1378\/chest.128.2.525","article-title":"Causes and timing of death in patients with ARDS.","volume":"128","author":"Stapleton","year":"2005","journal-title":"Chest"},{"key":"R15-20240822","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s13054-020-03108-w","article-title":"Causes and characteristics of death in patients with acute hypoxemic respiratory failure and acute respiratory distress syndrome: A retrospective cohort study.","volume":"24","author":"Ketcham","year":"2020","journal-title":"Crit Care"},{"key":"R16-20240822","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/CCM.0000000000003022","article-title":"Is overall mortality the right composite endpoint in clinical trials of acute respiratory distress syndrome?","volume":"46","author":"Villar","year":"2018","journal-title":"Crit Care Med"},{"key":"R17-20240822","doi-asserted-by":"crossref","first-page":"00587-2020","DOI":"10.1183\/23120541.00587-2020","article-title":"Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: A cohort study.","volume":"6","author":"Gacouin","year":"2020","journal-title":"ERJ Open Res"},{"key":"R18-20240822","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(17)30213-8","article-title":"Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: Insights from the LUNG SAFE prospective cohort study.","volume":"5","author":"Laffey","year":"2017","journal-title":"Lancet Respir Med"},{"key":"R19-20240822","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1513\/AnnalsATS.201612-1042OC","article-title":"Management of acute respiratory distress syndrome and refractory hypoxemia. A multicenter observational study.","volume":"14","author":"Duan","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"R20-20240822","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1038\/s41598-022-14741-6","article-title":"Outcome of post-traumatic acute respiratory distress syndrome in young patients requiring extracorporeal membrane oxygenation (ECMO).","volume":"12","author":"Al-Thani","year":"2022","journal-title":"Sci Rep"},{"key":"R21-20240822","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12890-017-0520-5","article-title":"The impacts of baseline ventilator parameters on hospital mortality in acute respiratory distress syndrome treated with venovenous extracorporeal membrane oxygenation: A retrospective cohort study.","volume":"17","author":"Wu","year":"2017","journal-title":"BMC Pulm Med"},{"key":"R22-20240822","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/CCM.0000000000003081","article-title":"Open lung biopsy in nonresolving acute respiratory distress syndrome commonly identifies corticosteroid-sensitive pathologies, associated with better outcome.","volume":"46","author":"Gerard","year":"2018","journal-title":"Crit Care Med"},{"key":"R23-20240822","doi-asserted-by":"crossref","first-page":"00554-2022","DOI":"10.1183\/23120541.00554-2022","article-title":"Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality.","volume":"9","author":"Maamar","year":"2023","journal-title":"ERJ Open Res"},{"key":"R24-20240822","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S2213-2600(19)30138-9","article-title":"Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): A multicentre, single-blind, randomised controlled trial.","volume":"7","author":"Constantin","year":"2019","journal-title":"Lancet Respir Med"},{"key":"R25-20240822","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial.","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R26-20240822","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S2213-2600(17)30171-6","article-title":"Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): A randomised, double-blind, placebo-controlled phase 2 trial.","volume":"5","author":"McAuley","year":"2017","journal-title":"Lancet Respir Med"},{"key":"R27-20240822","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1053\/j.jvca.2019.05.035","article-title":"Streptokinase versus unfractionated heparin nebulization in patients with severe acute respiratory distress syndrome (ARDS): A randomized controlled trial with observational controls.","volume":"34","author":"Abdelaal Ahmed Mahmoud","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R28-20240822","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S2213-2600(21)00229-0","article-title":"Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): A prospective, multicentre cohort study.","volume":"9","author":"Estenssoro","year":"2021","journal-title":"Lancet Respir Med"},{"key":"R29-20240822","doi-asserted-by":"crossref","first-page":"154021","DOI":"10.1016\/j.jcrc.2022.154021","article-title":"Clinical characteristics, respiratory management, and determinants of oxygenation in COVID-19 ARDS: A prospective cohort study.","volume":"71","author":"Estenssoro","year":"2022","journal-title":"J Crit Care"},{"key":"R30-20240822","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13613-021-00943-0","article-title":"Impact of obesity on survival in COVID-19 ARDS patients receiving ECMO: Results from an ambispective observational cohort.","volume":"11","author":"Daviet","year":"2021","journal-title":"Ann Intensive Care"},{"key":"R31-20240822","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5114\/ait.2022.121091","article-title":"Respiratory mechanics in late COVID-19 ARDS\u2014a restrictive pattern is strongly associated with death. A cohort study.","volume":"54","author":"Pesta\u00f1a","year":"2022","journal-title":"Anaesthesiol Intensive Ther"},{"key":"R32-20240822","doi-asserted-by":"crossref","first-page":"e0770","DOI":"10.1097\/CCE.0000000000000770","article-title":"Outcomes of extracorporeal membrane oxygenation in COVID-19-induced acute respiratory distress syndrome: An inverse probability weighted analysis.","volume":"4","author":"Raasveld","year":"2022","journal-title":"Crit Care Explor"},{"key":"R33-20240822","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcrc.2021.10.017","article-title":"Death due to irreversible hypoxemic respiratory failure in ARDSnet clinical trials.","volume":"67","author":"Bosch","year":"2022","journal-title":"J Crit Care"},{"key":"R34-20240822","article-title":"Concept Paper on Revision of the Guideline on Clinical Investigation of Medicinal Products in the Treatment of Patients With Acute Respiratory Distress Syndrome. EMA\/CHMP\/175067\/2023 Rheumatology\/Immunology Working Party (RIWP) Committee for Medicinal Products for Human Use (CHMP).","year":"2023"},{"key":"R35-20240822","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: How to decide its appropriateness.","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Methodol"},{"key":"R36-20240822","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00134-020-06010-9","article-title":"Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis.","volume":"46","author":"Auriemma","year":"2020","journal-title":"Intensive Care Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T03:34:32Z","timestamp":1724384072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001147","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}